Utidelone Capsule Plus Capecitabine (CAP) for Metastatic Breast Cancer

Summary

This study aims to investigate the efficacy and safety of utidelone capsule plus Capecitabine in the treatment of advanced breast cancer , and thus provides a new systemic treatment strategy for those patients. This study was a single-arm, phase II study of patients with recurrent or metastatic HER2-negative breast cancer who had previously received chemotherapy regimens containing taxanes and/or anthracyclines were treated with a combination of utidelone capsules and capecitabine. The main objective was to explore the efficacy and safety of the combined regimen.

Timeline

Start

2024-06-05

Primary completion

2025-06-05

Completion

2025-12-05

Drugs

Indications